Paramount Skydance Corporation — Form 8-K
Reporting date: September 30, 2026. This is an event-driven filing, not a quarterly or annual financial report. It reports developments concerning the proposed merger with Warner Bros. Discovery (WBD).
Business context and transaction status
On September 30, 2026, the U.S. District Court for the Northern District of California entered a consent decree resolving the Plaintiff States’ antitrust lawsuit and modified the existing no-close order to permit the merger to close. The order permits closing; the filing does not say that the merger has closed. Under the February 27, 2026 merger agreement, WBD would become a wholly owned subsidiary of Paramount Skydance.
Paramount Skydance and WBD also settled a separate lawsuit brought by the Writers Guild of America (WGA). Both settlements resolve litigation without an admission of liability or wrongdoing.
Financial and operating information
- The filing provides no revenue, profit, cash-flow, margin, debt, or liquidity results for the period.
- Paramount Skydance said it does not expect the States Consent Decree or WGA settlement to materially affect its previously announced synergy and leverage targets. No target amounts or updated forecasts are provided here.
- Following merger closing, the combined company is required to spend at least $300 million more annually on U.S. production than Paramount Skydance and WBD spent combined in 2025, or $1.5 billion more over the five-year commitment period.
- The combined company must contribute $9.5 million annually for five years to specified workforce, film, and community programs, and $5 million annually during each commitment year to an Independent Film Fund.
- Within seven days after closing, Paramount Skydance must contribute $17.5 million to the Writers’ Guild-Industry Health Fund. Within 30 days after closing, it must pay WGA legal fees and costs, capped at $6 million.
- The combined company must reimburse the Plaintiff States’ reasonable legal and specified related costs, capped at $40 million.
Material commitments and contingencies
- Theatrical releases: During a five-year period after closing, the combined company must release at least 30 U.S. films annually in each of the first two years and 32 annually in each of the next three. Annual requirements also include minimum wide-release, independent-film, and company-produced or co-produced counts. Films must generally have a theatrical window of at least 45 days and cannot be available on SVOD for at least 90 days after initial U.S. theatrical exhibition.
- Potential remedies: After applicable cure periods and procedures, failure to meet annual film-release commitments may require divestiture of Miramax Studios. Each film below the applicable annual minimum also triggers a $30 million contribution, allocated among specified funds.
- Basic-cable negotiations: The company must negotiate affiliation terms separately for Paramount’s and WBD’s basic-cable portfolios and may not use confidential fee data from one portfolio in negotiations for the other. An uncured material breach may require divestiture of BET, VH1, Comedy Central, Smithsonian, Destination America, and Science.
- Other operating conditions: The combined company must retain the Paramount and Warner Bros. studio lots and use commercially reasonable efforts to operate them consistently with past practices; honor existing collective bargaining agreements and bargain in good faith; and maintain Pluto TV, or a substantially equivalent successor, as a free ad-supported streaming service at specified minimum service levels.
- News and workforce: Within 180 days after closing, the combined company must establish a five-member News Editorial Independence Board to address specified editorial matters relating to CBS News and CNN. During the commitment period, CBS News Broadcast must maintain WGA-represented full-time staff at least at the closing-date baseline, subject to a six-month cure period.
- The States Consent Decree also requires compliance monitoring, including an internal Compliance Monitor, an independent Monitoring Trustee, and semiannual reporting.
Outlook, commentary, and risks
Management’s stated view is that the settlements are not expected to materially affect previously announced synergy and leverage targets. The filing gives no updated financial outlook. The obligations described above are contingent on merger closing and include cure periods, monitoring, and potential divestitures or payments for specified breaches.
The filing highlights risks including failure to satisfy merger closing conditions or delays; inability to realize expected merger benefits or synergies; integration challenges; substantial indebtedness and the ability to deleverage or obtain financing; operating, advertising, streaming, distribution, labor, litigation, regulatory, cybersecurity, and market risks; and risks related to the company’s ownership and governance structure. Forward-looking statements are subject to these and other uncertainties.
Important facts for investors to verify
- Whether and when the WBD merger closes, and whether all remaining closing conditions are satisfied.
- The final merger financing, debt, liquidity, and leverage profile, which this filing does not quantify.
- How the five-year consent-decree obligations affect actual production spending, release schedules, costs, and synergy realization.
- Whether any film-release, cable-negotiation, Pluto TV, news-independence, or workforce requirements trigger remedies or additional costs.
- The amounts and timing of merger-related synergies and deleveraging targets in subsequent company disclosures.